(600223)"LUSHANG FREDA PHARMACEUTICAL CO., LTD."Announcement on Appointment of Senior Executives
Filed with SSE · Stock code 600223 · · 2 pages · Chinese
Summary by 6ix AI
Lushang Freda Pharmaceutical Co., Ltd. announced the appointment of senior executives.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Lushang Freda Pharmaceutical Co., Ltd. on 6ix
Story so far
- (600223)"LUSHANG FREDA PHARMACEUTICAL CO., LTD."Announcement on Departure of Director and Senior Executive
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026
- Announcement on Completion of Transfer Registration of Certain Company Shares by the Controlling Shareholder through Agreement
Earlier from Lushang Freda Pharmaceutical
- (600223)"LUSHANG FREDA PHARMACEUTICAL CO., LTD."Announcement on Departure of Director and Senior Executive
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026
- Announcement on Completion of Transfer Registration of Certain Company Shares by the Controlling Shareholder through Agreement
- Notice on Convening the 2nd Extraordinary General Meeting in 2026
- Announcement on Signing of the Financial Services Agreement with Shandong Commercial Group Finance Co., Ltd. and Related Party Transactions
Follow Lushang Freda Pharmaceutical into a list and get an email when it puts out news.
Follow Lushang Freda Pharmaceutical